Loading...
 
Home > Խ >
 
 
  2020 11 α׷ 2020-12-16
 
               



                                                                                                    



    
 
 2021 2 ġ α׷
 2020 10 α׷
 
Ʈ
ۼ йȣ
 
 
 
, Cveti nedorogo_kyei (2026-04-01)
߬֬լԬڬ ܬѬڬӬ Ҭܬ֬ https://cveti-nederogo.ru/ .
 
 
 
, SusiePaG (2026-04-01)
֬լ֬䬳ݬѬ ֬լѬӬݬ֬ Ҭڬ߬ ӬҬ ܬѬ֬Ӭ֬߬߬ ڬ٬լ֬ݬڬ ڬ ֬լܬڬ ެѬ֬ڬѬݬ. ӬѬج߬, ܬѬܬڬ Ҭ֬ެ ӬѬ ߬֬Ҭլڬެ ެ֬ݬܬڬ Ѭڬ լ ԬݬҬѬݬ߬ ѬӬ, ެ ҬݬլѬ֬ ܬѬѬ۬ڬ ܬ ӬѬ֬Ԭ ٬ѬܬѬ٬.

ѬجլѬ ֬լڬ߬ڬ ӬѬ լӬ֬جլ֬߬ ݬѬԬѬڬެڬ լܬެ֬߬Ѭެ, լӬ֬جլѬڬެ ڬ ڬجլ֬߬ڬ. ج֬ݬҬ߬Ѭ ެ ٬Ѭݬ ߬Ѭ֬Ԭ ֬ ެ ߬ Ӭ٬, Ҭ ߬ ӬѬ Ӭ ֬լѬӬݬ ֬֬߬ڬ ֬ҬӬѬ߬ڬ ӬѬ֬Ԭ Ҭڬ٬߬֬.

Ӭ֬ ٬ѬӬܬ ߬ Ѭ֬ ֬ڬѬݬڬѬ ֬լ֬䬳ݬѬ Ҭ֬լڬ֬ ެ߬ج֬Ӭ ߬Ѭڬ ֬ڬެ֬.

Ѭ լܬڬ:
Ӭݬܬ ެݬڬҬլ֬߬ӬѬ Ӭݬܬ ެݬڬҬլ֬߬ӬѬ - ӬܬܬѬ֬Ӭ֬߬߬ ެѬ֬ڬѬ, ܬ ڬܬ ڬݬ٬֬ Ѭ٬ݬڬ߬ Ѭݬ ެݬ֬߬߬. ߬ ҬݬѬլѬ֬ Ӭܬڬ Ӭ߬֬ ߬ ۬ڬӬ Ӭܬڬ ֬ެ֬ѬѬ, լ֬ݬѬ֬ ֬ ڬլ֬Ѭݬ߬ ӬҬ լݬ ڬ٬ӬլӬ ݬ֬Ԭܬڬ ܬ߬ܬڬ լ֬Ѭݬ֬. ݬѬԬլѬ Ӭڬ ߬ڬܬѬݬ߬ Ӭ۬ӬѬ, Ӭݬܬ ެݬڬҬլ֬߬ӬѬ լլڬ լݬ ڬݬ٬ӬѬ߬ڬ ݬ֬ܬ߬ڬܬ, ڬެڬ֬ܬ ެݬ֬߬߬ ެ֬ѬݬݬԬڬ. ݬ Ӭ ڬ ܬڬ Ӭݬܬ ެݬڬҬլ֬߬ӬѬ , Ӭ լ֬ݬѬ֬ ѬӬڬݬ߬ ӬҬ, Ҭ֬֬ڬ Ӭ ֬ܬ ߬Ѭլ֬ج߬ լݬԬӬ֬߬ ެѬ֬ڬѬݬ.
 
 
 
, Cveti nedorogo_kkei (2026-04-01)
ܬڬ Ӭ֬ ެܬӬ լѬӬܬ ߬֬լԬ ߬ լ ֬Ԭլ߬ https://www.cveti-nederogo.ru .
 
 
 
, Cveti nedorogo_uqei (2026-04-01)
Ӭ֬ ߬ ݬ֬ܬ٬ѬӬլܬ Ӭ٬ݬ ެ֬ Ӭ֬ ߬ ݬ֬ܬ٬ѬӬլܬ Ӭ٬ݬ ެ֬ .
 
 
 
, WilliamSEede (2026-03-31)
Zoya Demidenko: Scholar in Tumor Science
Zoya Demidenko is a prominent scholar affiliated with the Division of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a solid foundation in life science study.
Demidenko's scientific work spans several pivotal domains, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cell senescence, and cancer biology. To date, she has written more than 46 peer-reviewed papers, which have received upwards of 4,100 references a reflection to the influence of her work.
Among her key contributions lies in elucidating the pathways of cellular senescence. Her studies demonstrated that when the cell cycle is blocked but cellular growth persists, the cells experience senescence. Importantly, Zoya Demidenko showed that this transition is pharmacologically suppressed using compounds such as rapamycin.
Zoya Demidenko has also brought greatly to tumor management investigation, particularly in the domain of cyclotherapy a strategy intended to protecting non-cancerous tissue from cytotoxic treatment whilst leaving tumor cells exposed. This approach carries significant hope for lowering the adverse effects of oncological therapy.
Throughout her career, Demidenko has worked with top investigators internationally, such as Dr. Mikhail Blagosklonny. Her work can be found in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
<>1.03.2026 11:21] Ѭ: With an h-index of 33, Zoya Demidenko ranks as a widely cited voice in contemporary oncological science, whose discoveries go on to guide our knowledge of the way cells grow old, resist treatment, and the ways in which malignant disease can be more successfully combated.
https://www.aging-us.com/article/100421/
 
 
   11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 
 
 
 
개인정보 처리방침